Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Botswana runs short on ARVs, Zimbabwe bails
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 67039, member: 636"] Botswana received a shipment of anti-retroviral drugs from Zimbabwe to steady HIV treatment after temporary shortages in Gaborone. The consignment left Harare on Oct. 29, 2025, and arrived Oct. 30, combining a donation and a loan valued at about $600,000. Officials said twenty percent was donated and eighty percent will be repaid in kind once Botswana’s supply recovers. The move aims to prevent treatment gaps linked to global procurement delays. Zimbabwe’s National Pharmaceutical Company coordinated the dispatch, with Botswana’s ambassador Sarah Molosiwa observing the send-off. The assistance reflects Zimbabwe’s push to rebuild medicine production, marked by a new NatPharm warehouse opened in Mutare on Oct. 24. Botswana’s health ministry said the shipment will stabilize distribution as the country manages one of the world’s highest HIV rates, near 20 percent among adults. Unions and health advocates in the region have pointed to the step as a model for cross-border support within the Southern African Development Community, where past exchanges have helped countries ride out short-term supply shocks. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Botswana runs short on ARVs, Zimbabwe bails
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top